PPP

CTCP Dược phẩm Phong Phú ·HNX

·

▲▲ Improving positively

Price 18,000
P/E 7.1x
P/B 1.1x
Updated 30 Jun 2026

On a TTM 2026Q1 basis, PPP has not accelerated revenue sharply, but profitability is improving visibly — the growth momentum has held across consecutive periods. Profit growth is driven mainly by better operations rather than scale expansion — a foundation that tends to be more durable.

Revenue TTM: VND 142bn (+0.5%) Net Margin: 17.45% (+3.8pp year on year) ROE: 17.3%

Same Sector

DHG, DVN, IMP, DBD